Literature DB >> 2031269

Effective treatment of cyclosporine-induced cholestasis in heart-transplanted patients treated with ursodeoxycholic acid.

B Kallinowski1, L Theilmann, R Zimmermann, E Gams, B Kommerell, A Stiehl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2031269     DOI： 10.1097/00007890-199105000-00041

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Drug-Induced Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Anastasios Armonis; Michalis Economou; Alec Avgerinos; Dimitrios Tzourmakliotis
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

3.  Chronic renal failure-induced changes in serum and urine bile acid profiles.

Authors:  F Jimenez; M J Monte; M Y El-Mir; M J Pascual; J J G Marin
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

4.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.